Endothelial dysfunction in acute renal failure: Role of circulating and tissue endothelin-1

Journal of the American Society of Nephrology

Volumn 10, Issue 5, 1999, Pages 953-962

  Ruschitzka, Frank ^a   Shaw, Sidney ^b   Gygi, Daniel ^b   Noll, Georg ^b   Barton, Matthias ^b   Lüscher, Thomas F ^b  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; ENDOTHELIN 1; ENDOTHELIN A RECEPTOR; ENDOTHELIN B RECEPTOR; MESSENGER RNA; NITROPRUSSIDE SODIUM;

ACUTE KIDNEY FAILURE; ANIMAL MODEL; ANIMAL TISSUE; ARTERY ENDOTHELIUM; ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RENAL ARTERY; VASOCONSTRICTION; VASODILATATION;

EID: 0032940042     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (61)

1. Lüscher TF, Vanhoutte PM: The Endothelium: Modulator of Cardiovascular Function, Boca Raton, CRC Press, 1990, pp 1-228
2. Shimokawa H, Vanhoutte PM: Hypercholesterolemia causes generalized impairment of endothelium-dependent relaxation to aggregating platelets in porcine arteries. J Am Coll Cardiol 13: 1402-1408, 1989
3. Lüscher TF, Vanhoutte PM: Endothelium-dependent contractions to acetylcholine in the aorta of the spontaneously hypertensive rat. Hypertension 8: 344-348, 1986
4. Gotto AM, Farmer JA: Risk Factors for Coronary Artery Disease, Philadelphia, Saunders, 1992
5. Zeiher AM, Drexler H, Saurbier B, Just H: Endothelium-mediated coronary blood flow modulation in humans: Effects of age, atherosclerosis, hypercholesterolemia, and hypertension. J Clin Invest 92: 652-662, 1993
6. Stroes ES, Joles JA, Chang PC, Koomans HA, Rabelink TJ: Impaired endothelial function in patients with nephrotic range proteinuria. Kidney Int 48: 544-550, 1995
7. Conger JD, Robinette JB, Hammond WS: Differences in vascular reactivity in models of ischemic acute renal failure. Kidney Int 39: 1087-1097, 1991
8. Lüscher TF, Boulanger CM, Dohi Y, Yang ZH: Endothelium-derived contracting factors. Hypertension 19: 117-130, 1992
9. Mino N, Kobayashi M, Nakajima A, Amano H, Shimamoto K, Ishikawa K, Watanabe K, Nishikibe M, Yano M, Ikemoto F: Protective effect of a selective endothelin receptor antagonist, BQ-123, in ischemic acute renal failure in rats. Eur J Pharmacol 221: 77-83, 1992
10. Espinosa G, Lopez Farre A, Cernadas MR, Manzarbeitia F, Tan D, Digiuni E, Mosquera JR, Monton M, Millas I, Hernando L, Casado S, Caramelo C: Role of endothelin in the pathophysiology of renal ischemia-reperfusion in normal rabbits. Kidney Int 50: 776-782, 1996
11. Sandok EK, Lerman A, Stingo AJ, Perrella MA, Gloviczki P, Burnett JC Jr: Endothelin in a model of acute ischemic renal dysfunction: Modulating action of atrial natriuretic factor. J Am Soc Nephrol 3: 196-202, 1992
12. Kon V, Sugiura M, Inagami T, Harvie BR, Ichikawa I, Hoover RL: Role of endothelin in cyclosporine-induced glomerular dysfunction. Kidney Int 37: 1487-1491, 1990
13. Heyman SN, Clark BA, Kaiser N, Epstein FH, Spokes K, Rosen S, Brezis M: In-vivo and in-vitro studies on the effect of amphotericin B on endothelin release. J Antimicrob Chemother 29: 69-77, 1992
14. Simonson MS, Dunn MJ: The molecular mechanisms of cardiovascular and renal regulation by endothelin peptides. J Lab Clin Med 119: 622-639, 1992
15. Moore K, Wendon J, Frazer M, Karani J, Williams R, Badr K: Plasma endothelin immunoreactivity in liver disease and the hepatorenal syndrome. N Engl J Med 327: 1774-1778, 1992
16. Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, Mitsui Y, Yazaki Y, Goto K, Masaki T: A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 332: 411-415, 1988
17. Sakurai T, Yanigasawa M, Masaki T: Molecular characterization of endothelin receptors. Trends Pharmacol Sci 13: 103-107, 1992
18. Sakurai T, Yanagisawa M, Takuwa Y, Miyazaki H, Kimura S, Goto K, Masaki T: Cloning of a cDNA encoding a non-isopeptide-selective subtype of the endothelin receptor. Nature 348: 732-735, 1990
19. Arai H, Hori S, Aramori I, Ohkubo H, Nakanishi S: Cloning and expression of a cDNA encoding an endothelin receptor [see Comments]. Nature 348: 730-732, 1990
20. Benigni A: Defining the role of endothelins in renal pathophysiology on the basis of selective and unselective endothelin receptor antagonist studies. Curr Opin Nephrol Hypertens 4: 349-353, 1995
21. Kohan DE, Fiedorek FT Jr: Endothelin synthesis by rat inner medullary collecting duct cells. J Am Soc Nephrol 2: 150-155, 1991
22. Karet FE, Davenport AP: Localization of endothelin peptides in human kidney. Kidney Int 49: 382-387, 1996
23. Badr KF, Murray JJ, Breyer MD, Takahashi K, Inagami T, Harris RC: Mesangial cell, glomerular and renal vascular responses to endothelin in the rat kidney: Elucidation of signal transduction pathways. J Clin Invest 83: 336-342, 1989
24. Firth JD, Schricker K, Ratcliffe PJ, Kurtz A: Expression of endothelins 1 and 3 in the rat kidney. Am J Physiol 269: F522-F528, 1995
25. Sakamoto H, Sasaki S, Nakamura Y, Fushimi K, Marumo F: Regulation of endothelin-1 production in rat mesangial cells. Kidney Int 41: 350-355, 1992
26. Raij L, Baylis C: Glomerular actions of nitric oxide [Editorial]. Kidney Int 48: 20-32, 1995
27. + exchange, c-fos expression, and mitogenesis in rat mesangial cells. J Clin Invest 83: 708-712, 1989
28. Resink TJ, Scott-Burden T, Boulanger C, Weber E, Buhler FR: Internalizazion of endothelin-1 by cultured vascular smooth muscle cells: Characterization and biological significance. Mol Pharmacol 38: 244-252, 1990
29. Gandhi CR: Vascular smooth muscle cells metabolize endothelin-1 in the absence of a functional receptor. Biochim Biophys Acta 1269: 290-298, 1995
30. Shiba R, Yanagisawa M, Miyauchi T, Ishii Y, Kimura S, Uchiyama Y, Masaki T, Goto K: Elimination of intravenously injected endothelin-1 from the circulation of the rat. J Cardiovasc Pharmacol 13: 98-101, 1989
31. B receptors in the rat. Biochem Biophys Res Commun 199: 1461-1465, 1994
32. Firth JD, Ratcliffe PJ, Raine AE, Ledingham JG: Endothelin: An important factor in acute renal failure? Lancet 2: 1179-1182, 1988
33. Kaasjager KA, Shaw S, Koomans HA, Rabelink TJ: Role of endothelin receptor subtypes in the systemic and renal responses to endothelin-1 in humans. J Am Soc Nephrol 8: 32-39, 1997
34. Rabelink TJ, Kaasjager KA, Boer P, Stroes EG, Braam B, Koomans HA: Effects of endothelin-1 on renal function in humans: Implications for physiology and pathophysiology. Kidney Int 46: 376-381, 1994
35. Benigni A, Zoja C, Corna D, Orisio S, Longaretti L, Bertani T, Remuzzi G: A specific endothelin subtype A receptor antagonist protects against injury in renal disease progression. Kidney Int 44: 440-444, 1993
36. Gellai M, Jugus M, Fletcher T, De Wolf R, Nambi P: Reversal of postischemic acute renal failure with a selective endothelin A receptor antagonist in the rat. J Clin Invest 93: 900-906, 1994
37. Clozel M, Breu V, Burri K, Cassai JM, Fischli W, Gray GA, Hirth G, Loffler BM, Muller M, Neidhart W: Pathophysiological role of endothelin revealed by the first orally active endothelin receptor antagonist. Nature 365: 759-761, 1993
38. Nabokov A, Amann K, Wagner J, Gehlen F, Munter K, Ritz E: Influence of specific and non-specific endothelin receptor antagonists on renal morphology in rats with surgical renal ablation. Nephrol Dial Transplant 11: 514-520, 1996
39. B endothelin antagonist, L-754,142, after aortic cross-clamping in the dog. J Am Soc Nephrol 8: 1061-1071, 1997
40. A-receptor blockade in angiotension II-induced hypertension. Hypertension 29: 435-441, 1996
41. Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162: 156-159, 1987
42. Lin HY, Kaji EH, Winkel GK, Ives HE, Lodish HF: Cloning and functional expression of a vascular smooth muscle endothelin-1 receptor. Proc Natl Acad Sci USA 88: 3185-3189, 1991
43. Fort P, Marty L, Piezchaczyk M, Sabrouty SE, Dani C, Jeanteur P, Blanchard JM: Various rat adult tissues express only one major mRNA species from glyceraldehyde-3-phosphate-dehydrogenase multigenic family. Nucleic Acids Res 13: 1431-1442, 1985
44. Tomita K, Ujie K, Nakanishi T, Tomura S, Matsuda O, Ando K, Shichiri M, Hirata Y, Marumo F: Plasma endothelin levels in patients with acute renal failure [Letter]. N Engl J Med 321: 1127, 1989
45. Roubert P, Cornet S, Plas P, Guilmard C, Pirotzky E, Chabrier PE, Braquet P: Upregulation of renal endothelin receptors in glycerol-induced acute renal failure in the rat. J Cardiovasc Pharmacol 22: S303-S305, 1993
46. Wagner OF, Christ G, Wojta J, Vierhapper H, Parzer S, Nowotny PJ, Schneider B, Waldhausl W, Binder BR: Polar secretion of endothelin-1 by cultured endothelial cells. J Biol Chem 267: 16066-16068, 1992
47. Lüscher TF, Oemar BS, Boulanger CM, Hahn AW: Molecular and cellular biology of endothelin and its receptors. Part II. J Hypertens 11: 121-126, 1993
48. Abassi ZA, Tate JE, Golomb E, Keiser HR: Role of neutral endopeptidase in the metabolism of endothelin. Hypertension 20: 89-95, 1992
49. B receptors mediate contraction to endothelin-1 in human blood vessels. Circulation 89: 1203-1208, 1994
50. Clavell A, Stingo A, Margulies K, Brandt RR, Burnett JC: Role of endothelin receptor subtypes in the in vivo regulation of renal function. Am J Physiol 268: F455-F469, 1995
51. Clozel M, Loffler BM, Breu V, Hilfiger L, Maire JP: Downregulation of endothelin receptors by autocrine products of endothelin-1. Am J Physiol 265: C118-C122, 1993
52. Nakamura T, Ebihara I, Fukui M, Osada S, Tomino Y, Masaki T, Goto K, Furuichi Y, Koide H: Renal expression of mRNAs for endothelin-1, endothelin-3 and endothelin receptors in NZB/W F1 mice. Ren Physiol Biochem 16: 233-243, 1993
53. Ruiz-Ortega M, Gomez-Garre D, Xue HL, Blanco J, Egido J: Quinapril decreases renal endothelin-1 expression and synthesis in a normotensive model of immune-complex nephritis. J Am Soc Nephrol 8: 756-768, 1997
54. Boulanger C, Lüscher TF: Release of endothelin from the porcine aorta: Inhibition of endothelium-derived nitric oxide. J Clin Invest 85: 587-590, 1990
55. Sigmon DH, Newman JM, Beierwaltes WH: Angiotensin II: Endothelium-derived nitric oxide interaction in conscious rats. J Am Soc Nephrol 4: 1675-1682, 1994
56. Ikeda U, Yamamoto K, Maeda Y, Shimpo M, Kanbe T, Shimada K: Endothelin-1 inhibits nitric oxide synthesis in vascular smooth muscle cells. Hypertension 29: 65-69, 1997
57. Hirata Y, Hayakawa H, Suzuki E, Kimura K, Kikuchi K, Nagano T, Hirobe M, Omata M: Direct measurements of endothelium-derived nitric oxide release by stimulation of endothelin receptors in rat kidney and its alteration in salt-induced hypertension. Circulation 91: 1229-1235, 1995
58. Conger J, Robinette J, Villar A, Raij L, Shultz P: Increased nitric oxide synthase activity despite lack of response to endothelium-dependent vasodilators in postischemic acute renal failure in rats. J Clin Invest 96: 631-638, 1995
59. Shaw SG, Weidmann P, Hodler J, Zimmermann A, Paternostro A: Atrial natriuretic peptide protects against ischemic acute renal failure in the rat. J Clin Invest 80: 1232-1237, 1987
60. Vallance P, Leone A, Calver A, Collier J, Moncada S: Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure. Lancet 329: 572-575, 1992
61. G-dimethyl-L-arginine, a potential endogenous nitric oxide inhibitor in dialysis patients. J Am Soc Nephrol 8: 1437-1442, 1997